Your browser doesn't support javascript.
loading
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.
Kendall Bártu, Michaela; Nemejcová, Kristýna; Michálková, Romana; Struzinská, Ivana; Hájková, Nikola; Hojný, Jan; Krkavcová, Eva; Laco, Jan; Matej, Radoslav; Drozenová, Jana; Méhes, Gábor; Fabian, Pavel; Hausnerová, Jitka; Svajdler, Marián; Skapa, Petr; Cibula, David; Zima, Tomás; Dundr, Pavel.
Afiliação
  • Kendall Bártu M; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic. michaela.kendallbartu@vfn.cz.
  • Nemejcová K; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Michálková R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Struzinská I; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Hájková N; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Hojný J; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Krkavcová E; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Laco J; The Fingerland Department of Pathology, Charles University, Faculty of Medicine Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic.
  • Matej R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studnickova 2, 12800 Prague 2, Prague, Czech Republic.
  • Drozenová J; Department of Pathology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, 10034, Prague, Czech Republic.
  • Méhes G; Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
  • Fabian P; Department of Pathology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady, 10034, Prague, Czech Republic.
  • Hausnerová J; Department of Pathology, Faculty of Medicine, University of Debrecen, 4032, Debrecen, Hungary.
  • Svajdler M; Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Skapa P; Department of Pathology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Cibula D; Sikl's Department of Pathology, The Faculty of Medicine and Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Zima T; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
  • Dundr P; Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Virchows Arch ; 483(4): 497-507, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37676270
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Virchows Arch Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Virchows Arch Ano de publicação: 2023 Tipo de documento: Article